Healthcare Stocks To Watch Today - November 11th

Key Points

• Seven high-dollar-volume healthcare stocks to watch are Eli Lilly, Moderna, UnitedHealth Group, Thermo Fisher Scientific, Johnson & Johnson, Humana, and Regeneron Pharmaceuticals.
• Wednesday trading was mixed: Thermo Fisher, Humana, and Regeneron rose, while Eli Lilly, Moderna, UnitedHealth, and Johnson & Johnson fell. Regeneron gained $12.29 to $928.35, and Humana rose $7.29 to $445.35.

Eli Lilly and Company, Moderna, UnitedHealth Group, Thermo Fisher Scientific, Johnson & Johnson, Humana, and Regeneron Pharmaceuticals are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceuticals, medical devices, health insurance, and hospital care. Investors may buy them to gain exposure to the healthcare industry, whose performance can be influenced by medical innovation, regulation, demographics, and demand for care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded down $5.49 during mid-day trading on Wednesday, hitting $1,426.80. The company's stock had a trading volume of 704,361 shares, compared to its average volume of 2,958,567. The firm has a market capitalization of $1.34 trillion, a P/E ratio of 46.32, a P/E/G ratio of 1.69 and a beta of 0.40. Eli Lilly and Company has a 1-year low of $850.51 and a 1-year high of $1,453.00. The firm has a 50-day simple moving average of $1,225.57 and a 200 day simple moving average of $1,104.56. The company has a current ratio of 1.39, a quick ratio of 1.00 and a debt-to-equity ratio of 1.17.

Read Our Latest Research Report on LLY

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

MRNA stock traded down $2.31 during trading on Wednesday, hitting $248.52. The stock had a trading volume of 3,833,382 shares, compared to its average volume of 12,601,403. Moderna has a 1-year low of $22.28 and a 1-year high of $280.80. The stock has a market cap of $100.56 billion, a price-to-earnings ratio of -34.89 and a beta of 1.16. The company's 50 day moving average price is $196.68 and its two-hundred day moving average price is $93.60. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.47 and a current ratio of 3.62.

Read Our Latest Research Report on MRNA

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH stock traded down $5.88 during midday trading on Wednesday, reaching $399.24. 1,701,528 shares of the company's stock traded hands, compared to its average volume of 7,193,043. UnitedHealth Group has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a market capitalization of $357.73 billion, a P/E ratio of 22.79, a PEG ratio of 1.44 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The business has a 50-day moving average price of $390.98 and a two-hundred day moving average price of $364.53.

Read Our Latest Research Report on UNH

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of Thermo Fisher Scientific stock traded up $4.79 during trading on Wednesday, reaching $722.99. The company had a trading volume of 796,025 shares, compared to its average volume of 2,253,800. Thermo Fisher Scientific has a fifty-two week low of $435.27 and a fifty-two week high of $727.56. The firm's fifty day moving average is $665.03 and its 200-day moving average is $555.61. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.41 and a current ratio of 1.81. The company has a market cap of $267.88 billion, a price-to-earnings ratio of 38.08, a price-to-earnings-growth ratio of 2.94 and a beta of 0.84.

Read Our Latest Research Report on TMO

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

NYSE JNJ traded down $3.02 on Wednesday, hitting $277.76. The stock had a trading volume of 1,720,349 shares, compared to its average volume of 7,938,919. The stock has a market cap of $668.66 billion, a price-to-earnings ratio of 42.10, a P/E/G ratio of 2.79 and a beta of 0.22. The company's 50-day moving average is $266.49 and its two-hundred day moving average is $248.93. Johnson & Johnson has a one year low of $193.07 and a one year high of $283.25. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.44.

Read Our Latest Research Report on JNJ

Humana (HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Humana stock traded up $7.29 during mid-day trading on Wednesday, hitting $445.35. The company's stock had a trading volume of 933,888 shares, compared to its average volume of 1,644,822. The stock's fifty day moving average price is $405.76 and its two-hundred day moving average price is $313.90. The company has a quick ratio of 1.74, a current ratio of 1.65 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $53.48 billion, a P/E ratio of 43.35, a P/E/G ratio of 2.46 and a beta of 0.65. Humana has a twelve month low of $163.11 and a twelve month high of $456.50.

Read Our Latest Research Report on HUM

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity.

Shares of NASDAQ:REGN traded up $12.29 during midday trading on Wednesday, hitting $928.35. 429,931 shares of the stock were exchanged, compared to its average volume of 831,433. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.89 and a current ratio of 3.35. Regeneron Pharmaceuticals has a 52-week low of $591.52 and a 52-week high of $991.73. The business's fifty day simple moving average is $809.24 and its two-hundred day simple moving average is $744.46. The company has a market capitalization of $96.04 billion, a PE ratio of 20.52, a P/E/G ratio of 1.22 and a beta of 0.10.

Read Our Latest Research Report on REGN

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.